立方制药：8月22日召开董事会会议

Group 1 - The core point of the article is that Lifan Pharmaceutical held its 23rd meeting of the 5th board of directors on August 22, 2025, where it reviewed the full and summary reports for the first half of 2025 [1] - For the first half of 2025, Lifan Pharmaceutical's revenue composition was as follows: 91.14% from the pharmaceutical industry, 7.71% from pharmaceutical retail, and 1.16% from other sources [1] - As of the report, Lifan Pharmaceutical's market capitalization was 7.3 billion yuan [1] Group 2 - The A-share market has seen trading volumes exceed 2 trillion yuan for eight consecutive days, indicating strong market activity [1] - Major brokerage firms are actively recruiting for the autumn season, with 25 different positions available, highlighting the industry's demand for talent [1]